mk 912 has been researched along with guanosine 5'-o-(3-thiotriphosphate) in 2 studies
| Studies (mk 912) | Trials (mk 912) | Recent Studies (post-2010) (mk 912) | Studies (guanosine 5'-o-(3-thiotriphosphate)) | Trials (guanosine 5'-o-(3-thiotriphosphate)) | Recent Studies (post-2010) (guanosine 5'-o-(3-thiotriphosphate)) |
|---|---|---|---|---|---|
| 60 | 3 | 2 | 5,542 | 8 | 368 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonhaus, DW; Chang, LK; Chang, TK; Daunt, DA; Eglen, RM; Hsu, SA; Jasper, JR; Lesnick, JD; Yamanishi, SS | 1 |
| Blue, DR; Dillon, MP; Eglen, RM; Jasper, JR; Lesnick, JD; MacLennan, SJ; Zhu, QM | 1 |
2 other study(ies) available for mk 912 and guanosine 5'-o-(3-thiotriphosphate)
| Article | Year |
|---|---|
Ligand efficacy and potency at recombinant alpha2 adrenergic receptors: agonist-mediated [35S]GTPgammaS binding.
Topics: Adenylyl Cyclases; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Cell Line; Cell Membrane; Cyclic AMP; Genetic Vectors; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Ligands; Mice; Protein Binding; Quinolizines; Radioligand Assay; Receptors, Adrenergic, alpha-2; Recombinant Proteins | 1998 |
alpha 2A-adrenoceptors, not I1-imidazoline receptors, mediate the hypotensive effects of rilmenidine and moxonidine in conscious mice. In vivo and in vitro studies.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cell Line; Dogs; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Hypotension; Imidazoles; Imidazoline Receptors; In Vitro Techniques; Male; Mice; Mice, Inbred Strains; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Oxazoles; Quinolizines; Receptors, Adrenergic, alpha-2; Receptors, Drug; Rilmenidine; Saphenous Vein; Transfection | 1999 |